You have searched for "Global stocks"
Showing 1-10 of 880
KUALA LUMPUR: Bursa Malaysia started Thursday on a muted note, in line with key Asian markets, in the absence of strong fund buying to spur interest.
KUALA LUMPUR: After the retail investor driven rebound on Bursa Malaysia on Thursday, blue chips made a slight retreat with some mild profit taking of Genting, Genting Malaysia and Public Bank in early Friday trade.
LONDON: Global stocks held near record highs on Thursday, as recent vaccine progress, Joe Biden's U.S. presidential election victory and hopes for further stimulus kept markets bullish. (US markets close for Thanks giving)
WASHINGTON: Asian shares dipped slightly on Thursday as the hot run up in global markets took a breather, with investors switching their focus from vaccine hopes to disappointing U.S. jobs data and new COVID-19 lockdowns.
NEW YORK: Stocks ended near the previous session record high on Wednesday as Wall Street bumped up against disappointing job market data, while oil continued to rise and the dollar weakened further.
HONG KONG (Bloomberg): The surging coronavirus is stoking fears of a fresh downturn for the world economy, heaping pressure on central banks and governments to lay aside other concerns and do more to spur demand.
KUALA LUMPUR: Blue chips extended their losses early Friday on news that US Treasury Secretary Steven Mnuchin wanted the government to stop providing pandemic relief for struggling businesses.
BEIJING (AP): Global stocks were mostly lower Thursday (Nov 19) after Wall Street slid amid anxiety over the economic fallout from rising coronavirus infections in the United States and Europe.
TOKYO/NEW YORK: Global shares stepped back on Wednesday as soft U.S. retail sales fuelled worries that rising coronavirus cases could stifle a still fragile economic recovery, dampening the euphoria from vaccine trial breakthroughs.
NEW YORK: A gauge of global stocks edged lower from a record on Tuesday, as rising coronavirus cases raised concerns about fresh lockdown measures and tamped down recent optimism over promising vaccine trial results.